The Bimatoprost Drug Pad-IOL (BIM-IOL) System, developed by SpyGlass Pharma, uses 2 drug-eluting pads attached to the lens to ...
In the pivotal BRUNELLO trial, both doses of remigromig, a Wnt pathway agonist, were noninferior to ranibizumab for diabetic ...
A session at AAO 2026 highlighted how big data and minimally invasive glaucoma surgery (MIGS) could be utilized to help ...
A vote taken by the sound of applause rang out during an early morning session at (AAO) 2026 annual meeting, where 2 experts discussed the pros and cons of using complement inhibitors to treat ...
Artificial intelligence (AI) could help close gaps in eye care for underserved communities, but only if the tools reach the ...
Access to emergency eye care remains a public health challenge, with gaps that affect patients and communities across the ...
At the American Academy of Ophthalmology (AAO) 2026 Annual Meeting, Michael F. Chiang, MD, director of the National Eye ...
Overall, the researchers concluded that GLP-1RAs had a protective association with the development of DME compared with ...
The opening session of AAO 2026 featured a keynote speech discussing how artificial intelligence (AI) will play a part in ...
Adults with colorectal cancer (CRC) in states that expanded Medicaid under the Affordable Care Act (ACA) had lower mortality ...
The FDA has approved olanzapine extended-release injectable suspension (Weltruza; Teva Pharmaceuticals), a once-monthly ...
Population Health, Equity & Outcomes is a quarterly publication dedicated to providing a platform for the exchange of research, policy analysis, and insights that aim to improve health outcomes and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results